The Human Factor in Data Security Breaches

A new report examining pharma sector exposure makes for sobering reading, especially in US The pandemic's exacerbation of the pharmaceutical industry's exposure to data breaches has been one of the many disquieting side effects of life under COVID-19. In showing the extent of this security compromise among the Fortune 500 top 20 pharma companies, Constella Intelligence's new study, Pharma Sector Exposures Report: 2018-2021 Digital Risk Findings and Trends, makes for particularly unnerving reading, comparing as it does the number and type of data breaches that occurred during the pandemic period (up to September 2021) with those that took place in the two years before COVID. According to IBM's 2021 Cost of Data Breach Report, the average cost of a pharma breach in 2021 was more than $5 million-the third-highest cost behind the financial and healthcare sectors.